HALISTER: Hologic to Buy Cynosure for $66.00/Shr in Cash

Hologic to Buy Cynosure for $66.00/Shr in Cash

(Bloomberg) -- Hologic agrees to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of ~$1.65b and an enterprise value of $1.44b net of cash.
  • HOLX sees deal adding to adj. EPS immediately
  • CYNO halted
  • NOTE: Yday, CYNO fell 6.5% after Allergan agreed to buy Zeltiq
  • Statement:Link
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
CYNO US (Cynosure Inc)
HOLX US (Hologic Inc)

To de-activate this alert, click here

UUID: 7947283